Testing an imaging scan to find gastrointestinal cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study checks how well the LUM Imaging System can detect cancers of the esophagus, colon, or pancreas during the time you are preparing for surgery. It’s mainly meant to see if the scan works safely and clearly for doctors to find cancer areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of esophageal, colorectal, or pancreatic adenocarcinoma (or certain related abnormal growths) from a biopsy or cytology, and you are scheduled for surgery (including some endoscopy-based removals).
- You must be 18 years or older and able to follow study instructions.
- You must be medically healthy enough for surgery or an endoscopic procedure and meet blood-test targets (white blood cells, neutrophils, and platelets).
- You must have heart rhythm (QTc) within limits and your blood pressure must not be dangerously high.
- If you can become pregnant, you must use reliable birth control during the study and for 60 days after the imaging medicine is given.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at healthy adults who have no symptoms or risk factors for pancreatic cancer to test a new imaging method that may help find early signs of the disease. If you join, you will have an endoscopic ultrasound (a thin tube with a camera passed to your stomach) to check your pancreas.
This study tests a new imaging agent (a special dye) that might help doctors see tumors more clearly in people with certain advanced cancers. You would receive the dye and then have scans to see if it highlights cancer areas.
This study is collecting information from people who may have pancreatic cancer to see how a new ultrasound imaging technique (called LINFU) works for helping doctors decide whether a biopsy is needed. Participation could provide better imaging to guide your care.
This study looks at how CT scans (detailed X-ray pictures) help diagnose pancreatic cancer or hepatobiliary (liver/bile duct) cancers. It may help your care team better decide what’s going on and plan next treatments.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This trial uses advanced imaging (ultrasound and CT) plus a blood test to predict how well your stomach cancer will respond to chemotherapy given before surgery. The goal is to personalize your treatment and improve outcomes.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.